Compare Johnson & Johnson (JNJ) vs Vanguard S&P 500 ETF (VOO) Price & Performance

Johnson & JohnsonTrade

Vanguard S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

Johnson & Johnson vs Vanguard S&P 500 ETF — how do they compare? Johnson & Johnson trades at $250.82 (market cap $598.96B), while Vanguard S&P 500 ETF trades at $687.56. The key difference: Johnson & Johnson pays a 2.15% dividend while Vanguard S&P 500 ETF pays none. Which is the better fit depends on your goals.

	JNJ	VOO
Market Cap	$598.96B	—
Volume	6,156,228	—
Sector	Health	Broad Market / Factor
52-Week High	$267.24	$698.29
52-Week Low	$164.36	$571.45
Enterprise Value	$631.90B	—
Dividend Yield	2.15%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $250.61, down 0.96% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $2.90 versus $2.84 expected, and revenue growth of 6.6% year-over-year. The stock shows robust profitability with a net income margin of 21.48% and ROE of 26.42%, supported by consistent dividend payments including the recent $1.34 per share declared for H1-2026.

JNJ presents a favorable investment case with analyst consensus price target of $279.33 implying ~11% upside, though rising debt-to-asset ratio to 24.06% in 2025 and volatile cash flow trends pose risks. The healthcare giant's diversified portfolio and raised full-year guidance underpin long-term stability, but investors should monitor execution amid competitive and regulatory pressures.

Vanguard S&P 500 ETF

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JNJ

Head and neck squamous cell carcinoma market to grow at 10.5% CAGR by 2036 driven by new immunotherapiesNa · 6 hours agoBullish 2025 tax law boosts US manufacturing jobs, wages, and growth across all 50 statesFox Business · 15 hours agoBullish DIVO ETF up 6.6% YTD but faces pressure from high Treasury yields and low volatility.24/7 Wall Street · 4 days agoNeutral View details →

VOO

Buy rating maintained on US index assets despite AI sector volatility and bubble concerns.Seeking Alpha · 5 hours agoBullish DIA ETF underperforms S&P 500 ETFs due to higher fees and price-weighted index design.24/7 Wall Street · 3 days agoBearish SPY ETF charges higher fees than its cheaper sibling SPYM with identical S&P 500 exposure.24/7 Wall Street · 4 days agoBearish View details →

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

About Vanguard S&P 500 ETF

VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.